| Publication | Date of Publication | Type |
|---|
| Investigating the heterogeneity of ``study twins | 2024-12-05 | Paper |
| Stakeholders' perspectives on current issues in data monitoring committees | 2024-12-05 | Paper |
| A dose finding design for seizure reduction in neonates | 2024-11-21 | Paper |
| Blinded continuous monitoring of nuisance parameters in clinical trials | 2024-11-13 | Paper |
| Blinded continuous information monitoring of recurrent event endpoints with time trends in clinical trials | 2024-10-30 | Paper |
| A Bayesian time-to-event pharmacokinetic model for phase I dose-escalation trials with multiple schedules | 2024-10-30 | Paper |
| Blinded sample size reestimation for negative binomial regression with baseline adjustment | 2024-10-29 | Paper |
| Adaptive trial designs in diagnostic accuracy research | 2024-10-29 | Paper |
| Sample size calculation for the augmented logrank test in randomized clinical trials | 2024-10-29 | Paper |
| A straightforward meta-analysis approach for oncology phase I dose-finding studies | 2024-10-29 | Paper |
| A conditional error function approach for adaptive enrichment designs with continuous endpoints | 2024-10-28 | Paper |
| Sample size re-estimation for clinical trials with longitudinal negative binomial counts including time trends | 2024-10-28 | Paper |
| Model averaging for robust extrapolation in evidence synthesis | 2024-10-28 | Paper |
| On the role of benchmarking data sets and simulations in method comparison studies | 2024-10-28 | Paper |
| Summarizing empirical information on between-study heterogeneity for Bayesian random-effects meta-analysis | 2024-10-28 | Paper |
| Blinded sample size recalculation in multiple composite population designs with normal data and baseline adjustments | 2024-07-15 | Paper |
| Blinded sample size recalculation in adaptive enrichment designs | 2024-06-05 | Paper |
| Design aspects of COVID‐19 treatment trials: Improving probability and time of favorable events | 2023-12-15 | Paper |
| Improving adaptive seamless designs through Bayesian optimization | 2023-12-15 | Paper |
| Bounds for the weight of external data in shrinkage estimation | 2023-11-27 | Paper |
| Exact change point detection with improved power in small‐sample binomial sequences | 2023-11-27 | Paper |
| Survival analysis for AdVerse events with VarYing follow‐up times (SAVVY): Rationale and statistical concept of a meta‐analytic study | 2023-11-27 | Paper |
| Adjusting for Publication Bias in Meta-Analysis via Inverse Probability Weighting Using Clinical Trial Registries | 2023-10-30 | Paper |
| Using the bayesmeta R package for Bayesian random-effects meta-regression | 2023-02-01 | Paper |
| Subgroup identification in individual participant data meta-analysis using model-based recursive partitioning | 2022-12-09 | Paper |
| On the role of data, statistics and decisions in a pandemic | 2022-10-12 | Paper |
| Random-effects meta-analysis of phase I dose-finding studies using stochastic process priors | 2021-10-14 | Paper |
| Survival analysis for AdVerse events with VarYing follow-up times (SAVVY)—estimation of adverse event risks | 2021-06-29 | Paper |
| Sample size recalculation in multicenter randomized controlled clinical trials based on noncomparative data | 2020-11-23 | Paper |
| Adaptive seamless clinical trials using early outcomes for treatment or subgroup selection: Methods, simulation model and their implementation in R | 2020-11-23 | Paper |
| Blinded Sample Size Reestimation in Non‐Inferiority Trials with Binary Endpoints | 2020-09-25 | Paper |
| A Comparison of Methods for Adaptive Treatment Selection | 2020-09-25 | Paper |
| Sample Size Recalculation in Internal Pilot Study Designs: A Review | 2020-09-24 | Paper |
| A Comparison of Procedures for Adaptive Choice of Location Tests in Flexible Two-Stage Designs | 2020-09-22 | Paper |
| A Bootstrap Procedure for Adaptive Selection of the Test Statistic in Flexible Two-Stage DesignsThis paper is based on a presentation given at the Workshop “Frontiers in Adaptive Designs”, 17.–18. 5. 2001, Vienna/Austria. | 2020-09-22 | Paper |
| Semi‐parametric analysis of overdispersed count and metric data with varying follow‐up times: Asymptotic theory and small sample approximations | 2020-01-15 | Paper |
| Random‐effects meta‐analysis of few studies involving rare events | 2019-08-22 | Paper |
| Contribution to the discussion of “When should meta‐analysis avoid making hidden normality assumptions?” A Bayesian perspective | 2019-02-12 | Paper |
| Meta-analytic-predictive use of historical variance data for the design and analysis of clinical trials | 2018-08-14 | Paper |
| Dose‐finding methods for Phase I clinical trials using pharmacokinetics in small populations | 2017-07-20 | Paper |
| Meta‐analysis of two studies in the presence of heterogeneity with applications in rare diseases | 2017-07-20 | Paper |
| Do we consent to rules of consent and confidentiality? | 2017-04-28 | Paper |
| Blinded versus unblinded estimation of a correlation coefficient to inform interim design adaptations | 2017-04-28 | Paper |
| A studentized permutation test for three-arm trials in the ‘gold standard’ design | 2016-11-16 | Paper |
| Evidence synthesis for count distributions based on heterogeneous and incomplete aggregated data | 2016-03-14 | Paper |
| Design and analysis of three-arm trials with negative binomially distributed endpoints | 2015-09-21 | Paper |
| Blinded and unblinded internal pilot study designs for clinical trials with count data | 2013-11-04 | Paper |
| Planning and analysis of three-arm non-inferiority trials with binary endpoints | 2006-01-01 | Paper |
| A note on change point estimation in dose-response trials | 2001-08-20 | Paper |
| A studentized permutation test in group sequential designs | N/A | Paper |
